Chapel Hill, NC1 Active Studies

Waldenstrom Macroglobulinemia Clinical Trials in Chapel Hill, NC

Find 1 actively recruiting waldenstrom macroglobulinemia clinical trials in Chapel Hill, NC. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
20
Enrolling

Recruiting Waldenstrom Macroglobulinemia Studies in Chapel Hill

About Waldenstrom Macroglobulinemia Clinical Trials in Chapel Hill

Waldenstrom macroglobulinemia is a rare type of non-Hodgkin lymphoma where cancer cells produce large amounts of an abnormal protein called macroglobulin. It progresses slowly and may not require immediate treatment. Options include targeted therapy, chemotherapy, and plasmapheresis.

There are currently 1 waldenstrom macroglobulinemia clinical trials recruiting participants in Chapel Hill, NC. These studies are seeking a combined 20 participants. Research is being sponsored by Gottfried von Keudell, MD PhD. Clinical trial participation is free and participants receive study-related medical care at no cost.

Waldenstrom Macroglobulinemia Clinical Trials in Chapel Hill — FAQ

Are there waldenstrom macroglobulinemia clinical trials in Chapel Hill?

Yes, there are 1 waldenstrom macroglobulinemia clinical trials currently recruiting in Chapel Hill, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chapel Hill?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.

Are clinical trials in Chapel Hill free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.

What waldenstrom macroglobulinemia treatments are being tested?

The 1 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for waldenstrom macroglobulinemia.

Data updated October 16, 2026 from ClinicalTrials.gov